SUN PHARMACEUTICAL INDUSTRIES
|
The Current P/S Ratio of SUN PHARMACEUTICAL INDUSTRIES is 7.21.
| Share Price | ₹1,707.6 | Feb 10,2026 |
| Market Cap | ₹409,692.5 Cr | |
| Sales-TTM | ₹56,809.1 Cr | TTM-Consolidated Results |
| Price/Sales | 7.21x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of SUN PHARMACEUTICAL INDUSTRIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹409,692.5 Cr] as on Feb 10,2026
(/) Sales [ ₹56,809.1 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 7.21x ]
Thus, for SUN PHARMACEUTICAL INDUSTRIES , the investors are currently willing to pay '7.21 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of SUN PHARMACEUTICAL INDUSTRIES !
The chart below summarizes the trend in P/S Ratio of SUN PHARMACEUTICAL INDUSTRIES over the last five years.
Historical PS (Price/Sales) ratio chart of SUN PHARMACEUTICAL INDUSTRIES
PS Ratio Performance Analysis for SUN PHARMACEUTICAL INDUSTRIES
- SUN PHARMACEUTICAL INDUSTRIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 6.25x.
- SUN PHARMACEUTICAL INDUSTRIES 's operated at median p/e ratio of 5.68x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SUN PHARMACEUTICAL INDUSTRIES 's p/e ratio peaked in Mar2024 at 8.02x.
- SUN PHARMACEUTICAL INDUSTRIES 's p/e ratio hit its five-year low in Mar2021 of 4.28x.
How does SUN PHARMACEUTICAL INDUSTRIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES | 56,809.1 | 7.21 | 409,692.5 |
| DIVIS LABORATORIES LTD | 10,029.0 | 16.34 | 163,866.0 |
| CIPLA LTD | 28,351.1 | 3.82 | 108,412.0 |
| TORRENT PHARMACEUTICALS LTD | 12,248.0 | 11.27 | 138,062.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 3.02 | 104,805.0 |
| MANKIND PHARMA LTD | 13,914.1 | 6.15 | 85,533.2 |
| ZYDUS LIFESCIENCES LTD | 26,089.3 | 3.42 | 89,273.1 |
| LUPIN LTD | 24,750.7 | 4.07 | 100,736.0 |
| AUROBINDO PHARMA LTD | 33,181.9 | 1.96 | 65,186.3 |
| ABBOTT INDIA LTD | 6,714.4 | 8.64 | 58,041.8 |
| ALKEM LABORATORIES LTD | 13,890.2 | 5.00 | 69,507.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SUN PHARMACEUTICAL INDUSTRIES 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 1.96x |
| Max industry PS | 16.34x |
| Median industry PS | 5.00x |
| Average industry PS | 6.45x |
You may also like the below Video Courses